The record starts accreting with the next priced report.
2-quarter memory
Positioning
6 expiries · as of the Sep 16 close
Contracts already committed, not just traded today. Puts against calls, sized by expiry.
4,472
▲ 0%
Sep 18
2d
▲ 0%
12,927
193
▲ 2%
Oct 16
30d
▲ 0%
510
5,591
▲ 1%
Nov 20
65d
▲ 1%
3,812
701
▲ 14%
Dec 18
93d
▲ 8%
1,077
6,692
▲ 1%
Jan 15
121d
▲ 0%
6,535
346
▲ 0%
Feb 19
156d
▲ 1%
860
putscalls
Revenue flow
Q1 FY2027 as filed · change vs Q4 FY2026
DOCS kept 15.53% of Q1 FY2027 revenue as profit. Revenue +7.74% on Q4 FY2026, +7.34% on Q1 FY2026.
Revenue
$157M▲ +7.74% q/q
Gross profit
$133M▲ +5.53% q/q
84.87% margin
Cost of revenue
$24M▲ +22.08% q/q
Operating income
$34M▲ +35.52% q/q
21.48% margin
Operating expenses
$99M▼ −1.84% q/q
Marketing $45M
R&D $38M
SG&A $16M
Pre-tax income
$40M▲ +25.66% q/q
Net income
$24M▲ +27.21% q/q
15.53% margin
Tax
$16M▲ +23.38% q/q
Other income
$7M▼ −7.90% q/q
Revenue$157M
Gross profit$133M84.87%
Operating income$34M21.48%
Pre-tax income$40M
Net income$24M15.53%
Cost of revenue
$24M · 15.13%
Operating expenses
$99M · 63.39%
Tax
$16M · 10.25%
Other income joins
$7M · 4.29%
Standardized lines from DOCS’s own filing for the quarter ended Jun 30 '26. Ribbon thickness is the dollar amount.
Event sensitivity
release-day history · not a forecast
NFPjobs report2.5×up 3 of 8±5.5% vs ±2.2% · 8
PPIproducer prices1.6×up 2 of 9±3.5% vs ±2.2% · 9
CPROFcorporate profits0.9×up 6 of 10±2.1% vs ±2.2% · 10
PCEpersonal income & outlays0.9×up 10 of 17±2.1% vs ±2.2% · 17
GDPgross domestic product0.9×up 10 of 17±1.9% vs ±2.2% · 17
CPIconsumer prices0.9×up 2 of 9±1.9% vs ±2.2% · 9
FOMCrate decision0.6×up 9 of 24±1.2% vs ±2.2% · 24
How DOCS has moved on past release days against its ordinary ±2.2% day, and how often it closed up. Measured from our own stored closes. History, not a forecast; kinds with fewer than six past releases are omitted rather than shown thin.